Follow
Idogen AB
Nasdaq First North Sweden (Sweden)
Idogen AB is a Swedish biotech company engaged in developing tolerogenic cell therapies to prevent biological drugs, transplanted or body cells or tissues from being attacked by the patient's immune system. Its product IDO 8, treats patients with severe hemorrhagic disease.
Sector:
HEALTH CARE
>
Biotechnology
Healthcare
Media
News
1 2 3 4 5
Show

30

Instruments & Events
The shares and options available for this company. Including past events like IPOs, direct listings and exercise periods.
Show archived
Type
Ticker
ISIN
Market
SHARE
IDOGEN
SE0014428561
Nasdaq First North Sweden
Sweden (SE)
Details of share in Idogen AB with ticker IDOGEN
Status
Active
Order book id
4134
Amount of instruments
9 121 654
Par value
0.7000
Market cap
54 500 000.00 SEK
Currency
SEK
Segment
First North
First trading date
12 Jun 2015
Terms
Type
Price
Pre-money valuation
Time
Files
IPO
6.85 SEK
49.9M SEK
23 Apr - 08 May 2015
IPO in Idogen AB
Type
Price
Pre-money valuation
Time
Files
Exercise
08 Sep - 29 Sep 2016
Option exercise terms for IDOGEN TO1
Type
Price
Pre-money valuation
Time
Files
New issue
6.00 SEK
73.3M SEK
24 May - 12 Jun 2017
Share issue in Idogen AB
Type
Price
Pre-money valuation
Time
Files
Exercise
03 May - 18 May 2018
-
Option exercise terms for IDOGEN TO2
Type
Price
Pre-money valuation
Time
Files
New issue
1.75 SEK
36M SEK
20 Nov - 05 Dec 2018
Share issue in Idogen AB
Type
Price
Pre-money valuation
Time
Files
Exercise
6.00 SEK
19 Mar - 01 Apr 2019
-
Option exercise terms for IDOGEN TO3
Type
Price
Pre-money valuation
Time
Files
Rights issue
0.60 SEK
29.1M SEK
02 Mar - 16 Mar 2020
Share issue in Idogen AB
Type
Price
Pre-money valuation
Time
Files
Market move
6.14 SEK
56M SEK
04 Jun 2020
Listing of Idogen AB on Nasdaq First North Sweden
Type
Ticker
ISIN
Market
SHARE
IDOGEN
SE0006887386
Nasdaq First North Sweden
Sweden (SE)
Details of share in Idogen AB with ticker IDOGEN
Status
Archived
Order book id
4134
Amount of instruments
91 216 533
Par value
0.0700
Market cap
56 400 000.00 SEK
Currency
SEK
First trading date
12 Jun 2015
Terms
Update (20.05.2020): Company’s ISIN code will change as a result of the consolidation of shares (1:10).
Type
Price
Pre-money valuation
Time
Files
IPO
6.85 SEK
49.9M SEK
23 Apr - 08 May 2015
IPO in Idogen AB
Type
Price
Pre-money valuation
Time
Files
New issue
6.00 SEK
73.3M SEK
24 May - 12 Jun 2017
Share issue in Idogen AB
Type
Price
Pre-money valuation
Time
Files
New issue
1.75 SEK
36M SEK
20 Nov - 05 Dec 2018
Share issue in Idogen AB
Type
Price
Pre-money valuation
Time
Files
Rights issue
0.60 SEK
29.1M SEK
02 Mar - 16 Mar 2020
Share issue in Idogen AB
Type
Ticker
ISIN
Market
SHARE
IDOGEN
SE0014428561
Nasdaq First North Sweden
Sweden (SE)
Details of share in Idogen AB with ticker IDOGEN
Status
Active
Order book id
4134
Amount of instruments
9 121 654
Par value
0.7000
Market cap
54 500 000.00 SEK
Currency
SEK
Segment
First North
Terms
Type
Price
Pre-money valuation
Time
Files
Market move
6.14 SEK
56M SEK
04 Jun 2020
Listing of Idogen AB on Nasdaq First North Sweden
Type
Ticker
ISIN
Market
OPTION
IDOGEN TO1
SE0006887394
Nasdaq First North Sweden
Sweden (SE)
Details of option in Idogen AB with ticker IDOGEN TO1
Status
Archived
Order book id
Amount of instruments
Market cap
Currency
SEK
First trading date
Terms
Type
Price
Pre-money valuation
Time
Files
Exercise
08 Sep - 29 Sep 2016
Option exercise terms for IDOGEN TO1
Type
Ticker
ISIN
Market
OPTION
IDOGEN TO2
SE0009895618
Nasdaq First North Sweden
Sweden (SE)
Details of option in Idogen AB with ticker IDOGEN TO2
Status
Archived
Order book id
Amount of instruments
Market cap
Currency
SEK
First trading date
Terms
Type
Price
Pre-money valuation
Time
Files
Exercise
03 May - 18 May 2018
-
Option exercise terms for IDOGEN TO2
Type
Ticker
ISIN
Market
OPTION
IDOGEN TO3
SE0009895626
Nasdaq First North Sweden
Sweden (SE)
Details of option in Idogen AB with ticker IDOGEN TO3
Status
Archived
Order book id
40YB
Amount of instruments
1
Market cap
Currency
SEK
First trading date
Terms
Update: The price was set at the lowest possible price 6 SEK. As this is multiple times higher then the market price nobody should excercise their options.

Each 1 option gives the holder the right to subscribe for 1 new share. The exercise price is set as 70 % of the volume weighted average market price during 25 February - 15 March 2019. But now lower than 6 SEK and not higher than 13 SEK.
Type
Price
Pre-money valuation
Time
Files
Exercise
6.00 SEK
19 Mar - 01 Apr 2019
-
Option exercise terms for IDOGEN TO3
People
Number of Employees
9 people
Anders Karlsson
CEO
Agneta Edberg
Chairman of the board
Christina Herder
Board member
Leif G Salford
Board member
Sharon Longhurst
Board member
Company Details
Sector
HEALTH CARE
Website

Address
C/O Medicon Village
Zip code
223 81
City/district
Lund
Country
Sweden (SE)
Registration number
556756-8521
LEI code
549300ERF656YVUYXS32
First trade date
12 Jun 2015
Registration date
24 Apr 2008
Short name
Idogen

We use cookies to make your experience using IPOhub better. By using our site you agree to our use of cookies. Learn More

Create Your FREE Account to stay Up To Date